Oryzon Genomics S.A. (ORY.MC)

EUR 2.66

(1.33%)

Gross Profit Summary of Oryzon Genomics S.A.

  • Oryzon Genomics S.A.'s latest annual gross profit in 2023 was 13.94 Million EUR , up 84.71% from previous year.
  • Oryzon Genomics S.A.'s latest quarterly gross profit in 2024 Q3 was - EUR , down -100.0% from previous quarter.
  • Oryzon Genomics S.A. reported a annual gross profit of 15.23 Million EUR in annual gross profit 2022, up 54.36% from previous year.
  • Oryzon Genomics S.A. reported a annual gross profit of 9.86 Million EUR in annual gross profit 2021, up 9.73% from previous year.
  • Oryzon Genomics S.A. reported a quarterly gross profit of - EUR for 2024 Q3, down -100.0% from previous quarter.
  • Oryzon Genomics S.A. reported a quarterly gross profit of - USD for 2024 Q1, down -100.0% from previous quarter.

Annual Gross Profit Chart of Oryzon Genomics S.A. (2023 - 2019)

Historical Annual Gross Profit of Oryzon Genomics S.A. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 13.94 Million EUR 84.71%
2022 15.23 Million EUR 54.36%
2021 9.86 Million EUR 9.73%
2020 8.99 Million EUR 0.0%
2019 - EUR 0.0%

Peer Gross Profit Comparison of Oryzon Genomics S.A.

Name Gross Profit Gross Profit Difference
Atrys Health, S.A. 52.61 Million EUR 73.49%
Biotechnologies Assets SA 3.45 Million EUR -303.37%
Pharma Mar, S.A. 148.54 Million EUR 90.61%
Laboratorios Farmaceuticos Rovi, S.A. 492.28 Million EUR 97.167%